Friday, July 10, 2026

pharma · Chronic Immune Thrombocytopenia (ITP)

Kedrion

Kedrion clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Barga, IT HQ
2,667 Employees
EMA registrant Type
Company details
Status
Public
HQ
Barga, IT
Employees
2,667
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

Kedrion projects

1 ClinicalTrials.gov programs sponsored by Kedrion.

Kedrion has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. KIg10

    Kedrion S.p.A.

    Chronic Immune Thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Kedrion have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.